【摘 要】
：
We developed an in situ protein-induced pluripotency-based cell reprogramming technique that directly performs cell reprogramming in the diseased tissues to generate transient stem cells that differen
【机 构】
：
Department of Biochemistry and Molecular Biology, Wayne State University, USA
【出 处】
：
第17届中国南方国际心血管病学术会议
论文部分内容阅读
We developed an in situ protein-induced pluripotency-based cell reprogramming technique that directly performs cell reprogramming in the diseased tissues to generate transient stem cells that differentiate into normal tissue cells under the tissue environment.
其他文献
目的 研究在主动脉夹层腔内修复术(TEVAR)中采用腹股沟斜行切口或Perclose血管闭合器的术后效果.方法 回顾性分析20例在我院行TEVAR患者分别采用腹股沟斜行切口分离股动脉穿刺(15例)和采用双Perclose闭合器(5例)两种方法,并进行成分效果分析,以直接医疗收费代替成本,术后入路血管并发症(包括出血、股动脉血肿、假性动脉瘤和淋巴漏)的发生和经济负担为直接效果进行分析,以VAS疼痛评
目的 利用CT三维成像研究心房颤动(房颤)患者行环肺静脉电隔离(CPVA)术后出现的肺静脉狭窄.方法 房颤患者共28例,行环肺静脉电隔离术(6.5±3.9)个月后进行随访.研究随访射频消融术后肺静脉的形态结果学特点和术前做对比分析.应用64排螺旋CT测量环肺静脉电隔离术前、后肺静脉口的径线,截面积,左房容积.
高血压已在我国形成广泛的流行态势,1/4的成年人罹患高血压.解决这一重大公共卫生问题必须从知晓每个人的血压入手,让每个居民共同参与,借助现代化技术和适宜工具,开展智能化的血压测量、风险评估与自我管理,才能真正实现高血压的有效防控.为此,我们从血压的自助测量入手,智能测量稳定血压值,开展心血管综合风险的自我评估与教育,借助连续闭环的自我血压管理系统,实现健康血压的终身维护与管理.
近年来粥样硬化性肾血管病(atherosclero-sisrenal artery stenosis,ARVD)患者中接受经皮肾动脉成形(percutaneous transluminal renal angioplasty,PTRA)治疗的数量迅速增加,PTRA正成为首选治疗方法。但目前对ARVD尚无公认的最优治疗,PTRA还是单纯药物保守治疗在学术界有很大争议,通过比较随机临床试验与真实世界的
Induced pluripotent stem cell (iPSC) can efficiently differentiate into functional cardiomyocytes through embryoid bodies (EBs) in the presence of specific signals.Recently, it has been suggested that
A 78-year-old woman with a history of chronic kidney disease, hypertension and diabetes mellitus presented with postprandial pain for one year.She had previously undergone left axillo-femoral bypass a
Anion Exchanger isoform 3 (AE3) is the major Cl-/HCO3-exchanger in mammalian cardiac myocytes.Gene targeted mice that lack AE3 exhibit normal cardiac performance under most conditions but develop seve
Novel therapeutic targets that can survive later clinical development process are urgently needed to treat obesity-related metabolic disorders.The current therapeutic paradigm is said to take 15 years
Hypertension or high blood pressure is the major risk factor for cardiovascular and renal disease that will affect 1.5 billion people in the next decade[1,2].The mechanisms for hypertension involves c
The endothelial progenitor cells (EPCs) are reduced in number and dysfunctional in diabetic patients.Determining the factors that impair EPC function could provide therapy targets for diabetes.Our pre